July 15, 2014

Rheonix to Showcase Automated Molecular Diagnostics Technology at American Association for Clinical Chemistry Annual Meeting

ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will address the need for access to critical advanced molecular testing, labor shortages that limit the availability of testing, and other obstacles laboratories face in adopting this technology at the American Association for Clinical Chemistry (AACC) Annual Meeting in Chicago, Illinois, July 27-31. Rheonix will display its Chemical and Reagent Device (CARD) and EncompassMDx™ molecular testing platform. The… Read More »